BIOAFFINITY TECHNOLOGIES, INC. (BIAF)
bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung
bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung
Cellebrite Announces Participation in Upcoming Investor Conferences USA - English APAC - Thai USA - Français MEXICO - Spanish BRAZIL - Portuguese APAC - English USA - Deutsch Japan - Japanese Korea - 한국어 USA - español Israel - English
CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates
Cellebrite kündigt Teilnahme an bevorstehenden Investorenkonferenzen an USA - Deutsch APAC - Thai Israel - English USA - Français MEXICO - Spanish BRAZIL - Portuguese APAC - English Japan - Japanese Korea - 한국어 USA - español
Timken Raises Quarterly Dividend to 36 Cents Per Share; Marking 13 Years of Increases
Arbor Realty Trust Reports First Quarter 2026 Results and Declares Dividend of $0.17 per Share